Combined mucormycosis and Aspergillosis of the rhinocerebral region

In Vivo. 2006 Mar-Apr;20(2):311-5.

Abstract

Background: Opportunistic fungal infections are rare, life-threatening conditions and are a major cause of morbidity and mortality in immunocompromised hosts. Our experience in the management of a case of combined mucormycosis and aspergillosis of the rhinocerebral region is presented.

Patients and methods: The infection developed a few weeks after tooth extraction, massively involving facial structures. After diagnosis, the patient underwent prolonged combined systemic antifungal treatment. Once the local and general conditions had stabilized, an extensive surgical debridement was performed, followed by reconstruction with a pedicled myocutaneous flap.

Results: This approach was curative with patient survival after 16 months.

Conclusion: Early diagnosis, early anti-fungal treatment and early stabilization of the patients' general condition are fundamental for patient survival. Surgery is necessary for fungal eradication, but must be performed according to the above conditions. Pedicled muscle flaps are considered the first reconstruction choice because of their excellent blood perfusion and resistance to fungal invasion.

Publication types

  • Case Reports

MeSH terms

  • Amphotericin B / therapeutic use
  • Antifungal Agents / therapeutic use
  • Aspergillosis / diagnosis
  • Aspergillosis / drug therapy
  • Aspergillosis / microbiology*
  • Aspergillus fumigatus / isolation & purification
  • Brain Abscess / diagnosis
  • Brain Abscess / drug therapy
  • Brain Abscess / microbiology*
  • Caspofungin
  • Combined Modality Therapy
  • Debridement
  • Drug Therapy, Combination
  • Echinocandins
  • Female
  • Humans
  • Lipopeptides
  • Middle Aged
  • Mucorales / isolation & purification
  • Mucormycosis / diagnosis
  • Mucormycosis / drug therapy
  • Mucormycosis / microbiology*
  • Otorhinolaryngologic Surgical Procedures
  • Paranasal Sinus Diseases / diagnosis
  • Paranasal Sinus Diseases / drug therapy
  • Paranasal Sinus Diseases / microbiology*
  • Peptides, Cyclic / therapeutic use
  • Plastic Surgery Procedures
  • Pyrimidines / therapeutic use
  • Tooth Extraction / adverse effects
  • Treatment Outcome
  • Triazoles / therapeutic use
  • Voriconazole

Substances

  • Antifungal Agents
  • Echinocandins
  • Lipopeptides
  • Peptides, Cyclic
  • Pyrimidines
  • Triazoles
  • Amphotericin B
  • Caspofungin
  • Voriconazole